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Objectives: Outcomes after carotid endarterectomy
(CEA) and carotid angioplasty and stenting (CAS) from
the Society for Vascular Surgery Vascular Registry (SVS-
VR) were ﬁrst reported in 2008. We present an updated
report on 30-day outcomes from the complete database.
Methods: There were 9865 procedures by 370 pro-
viders at 80 sites on 6492 CEA patients and 3373 CAS pa-
tients. The primary end point (major adverse coronary
event [MACE]) was a composite of death, stroke, and
myocardial infarction (MI) at 30 days.
Results: There were no statistically signiﬁcant differ-
ences in age or gender between CEA and CAS patients.
A total of 98.6% of CEA and 72.0% of CAS were treated
for atherosclerotic (ATH) disease. CAS patients were also
treated for restenosis (23.3%) and radiation (4.8%). CAS
patients were more likely to be symptomatic (45.4% vs
37.8%), with a higher prevalence of high-risk factors.
CAS patients had statistically signiﬁcant higher (P <
.0001) rates of MACE (6.76% vs 4.07%), stroke (4.77%
vs 2.53%), and mortality (1.84% vs 0.86%), but not MI
(1.30% vs 1.22%). The differences remained signiﬁcant af-
ter stratiﬁcation by symptomatology and multivariate logis-
tic regression analysis (Table).
Conclusions: An updated analysis using a large real-
world, multispecialty database demonstrated that CAS
was associated with higher rates of death and stroke
compared with CEA, even after controlling for differences
in these unmatched groups.Table. Unadjusted and adjusted odds ratios (OR) comparing
endarterectomy (CEA)
CAS (vs CEA) Unadjusted
Outcome Group OR 95% CI
Death/stroke/MI Entire cohort 1.71 1.43-2.05
Symptomatic 1.62 1.27-2.07
Asymptomatic 1.65 1.26-2.17
Stroke Entire cohort 1.93 1.55-2.41
Symptomatic 1.68 1.26-2.23
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Objectives: Spinal cord ischemia (SCI) is a devas-
tating, but potentially preventable complication of thoracic
endovascular aortic repair (TEVAR). The purpose of this
analysis was to determine what factors predict SCI after
TEVAR.
Methods: All TEVAR patients at a single institution
were reviewed for demographics, comorbidities, anatomic
centerline analysis, and procedural characteristics. A step-
wise-elimination logistic regression algorithm was used
and the model bootstrapped 1000 times to derive the
best subset of independent predictors.
Results: From 2002 to 2013, 741 patients under-
went TEVAR for various indications and 68 (9.2%)
developed SCI, which was permanent in 38 (5.1%).end points in carotid artery stenting (CAS) and carotid
OR Adjusted OR
P OR 95% CI P
<.0001 1.36 1.11-1.66 .0031
.0001 1.33 1.01-1.75 .0437
.0003 1.40 1.04-1.88 .0271
<.0001 1.64 1.29-2.08 <.0001
.0004 1.50 1.10-2.05 .0113
<.0001 1.80 1.23-2.63 .0024
Fig. Number needed to test (NNT) to prevent MACE-M.
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tiplies 1.3 per 10 years; 95% conﬁdence interval [CI]
0.9-1.8; P ¼ .06), aortic coverage length (OR multi-
plies 1.3 per 5 cm; 95% CI, 1.1-1.6; P ¼ .002),
chronic pulmonary disease (OR, 1.9; 95% CI, 0.9-4;
P ¼ .1), chronic renal insufﬁciency (creatinine $1.6;
OR, 1.9; 95% CI, 0.8-4.2; P ¼ .1), and hypertension
(chart history and/or medication; OR, 6.4; 95% CI,
2.6-18; P < .0001). The ﬁnal model included age,
aortic coverage length, and hypertension with excellent
discrimination (area under the curve ¼ .84) and cali-
bration (c2 ¼ 9.8; P ¼ .28; Fig).
Conclusions: This analysis yielded a simple model that
reliably predicts SCI after TEVAR. This clinical tool can
assist decision making regarding when to proceed with
TEVAR, guide discussions about intervention risk, and
help determine when maneuvers to mitigate SCI risk
should be implemented.
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Objectives: Bleeding complications are often under-
reported in thoracoabdominal aortic aneurysm (TAAA)
repair but are likely associated with signiﬁcant patient
morbidity and resource utilization. This study examines
the clinical characteristics and outcomes associated with
surgical bleeding in TAAA repair.
Methods: A retrospective review of a prospectively
maintained single-institution database was performed
from 1983 to 2009. Patient, aneurysm, and intraoperative
variables, as well as postoperative morbidity and mortality
associated with bleeding complications, were assessed using
univariable and multivariable analysis.
Results: Bleeding occurred in 71 of 781 TAAA repairs
(9.1%). Most bleeding complications, 69% (n ¼ 49), were
directly related to the procedure and 82% (n ¼ 40) of these
required reoperation. Of those with surgical bleeding, 25
(51%) stopped bleeding, leaving stable hematomas (95% of
which were evacuated later), 19 (39%) required repair of an
active surgical bleed (15% were reopened before leaving the
operating room and 85% returned to the operating room),
and ﬁve (10%) required splenectomy. Surgical bleeding did
not signiﬁcantly increase 30-day mortality (12% with bleeding
vs 8% without, P ¼ .28). However, surgical bleeding was
associated with a fourfold increase in paralysis risk (4.4% vs
16.7%, P ¼ .001) and increased length of hospital stay (30
vs 18 days, P < .0001). In univariate analysis, aneurysm
size, extent, renal function, age, and gender were not associ-
ated with increased surgical bleeding but deep hypothermic
arrest (P < .001) and acuity (P < .01) were. These variables
remained signiﬁcant (P < .05) in a multivariate model.Conclusions: Surgical bleeding after TAAA repair is
associated with increased resource utilization, including
reoperation, longer length of hospital stay, and increased
paraplegia. Efforts to reduce the high overall morbidity
associated with TAAA repair must include surgical tech-
niques and postoperative management strategies to mini-
mize surgical site bleeding and its sequelae.
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Objectives: To evaluate utilization of cardiac stress
testing (CST) before elective vascular surgery and deter-
mine its value in predicting adverse cardiac events.
Methods: Within the national Vascular Quality
Initiative (VQI), CST use was studied in 26,484 patients
undergoing elective carotid endarterectomy (CEA; n ¼
12,190), endovascular aneurysm repair (EVAR; n ¼
5255), open abdominal aortic aneurysm (AAA) repair (n
¼ 1,386), suprainguinal (n ¼ 2060), and infrainguinal
(n ¼ 5593) bypass between 2010 and 2012. The VQI
Cardiac Risk Index was used to stratify patient risk. Hos-
pital-level variation in CST utilization was measured. Pro-
pensity matching, receiver-operating characteristic curves,
and mixed-effects regression modeling assessed the pre-
dictive value of CST for postoperative major adverse car-
diac events or 30-day mortality (major adverse cardiac
events [MACE-M]).
Results: Use of CST varied dramatically (range, 0%-
100%) but MACE-M did not signiﬁcantly differ between
high and low utilization centers. These results were
conﬁrmed after propensity score and regression modeling.
A positive CST statistically improved the predictive value
for MACE-M over clinical risk stratiﬁcation for CEA, and
suprainguinal and infrainguinal bypasses, but not for
open AAA or EVAR. The number needed to test (NNT)
